Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Context Therapeutics Inc. | Former Section 16 officer | Stock Option (right to buy) | 29.2K | Feb 15, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CNTX | Context Therapeutics Inc. | Feb 15, 2022 | 1 | $0 | 4 | Feb 17, 2022 | Former Section 16 officer |
CNTX | Context Therapeutics Inc. | Oct 22, 2021 | 2 | $0 | 4/A | Dec 17, 2021 | SVP of R&D |
CNTX | Context Therapeutics Inc. | Oct 22, 2021 | 2 | $0 | 4 | Oct 25, 2021 | SVP of R&D |
CNTX | Context Therapeutics Inc. | Oct 19, 2021 | 0 | $0 | 3/A | Dec 17, 2021 | SVP of R&D |